Qualification of Drivers; Exemption Applications; Diabetes Mellitus, 38598-38599 [2010-16225]
Download as PDF
38598
Federal Register / Vol. 75, No. 127 / Friday, July 2, 2010 / Notices
emcdonald on DSK2BSOYB1PROD with NOTICES
Bethany Pisulak stated the following,
‘‘I feel that it is in the best safety to look
for possible downsides of these people
being able to work. They need to be
focused for a long time, meaning they
may go awhile without food or drink,
which could lower their sugars, making
them need insulin. There should be
multiple tests done to ensure that each
worker is qualified for the job or
position.’’
In response to this comment,
FMCSA’s exemption process supports
drivers with ITDM who seek to operate
in interstate commerce. In addition,
FMCSA relies on the expert medical
opinion of the endocrinologist and the
medical examiner, who are required to
analyze individual ability to control and
manage the diabetic condition,
including the individual ability and
willingness of the driver to monitor
blood glucose level on an ongoing basis.
Until the Agency issues a Final Rule,
however, drivers with ITDM must
continue to apply for exemptions from
FMCSA, and request renewals of such
exemptions. FMCSA will grant
exemptions only to those applicants
who meet the specific conditions and
comply with all the requirements of the
exemption.
Conclusion
Based upon its evaluation of the
thirty-three exemption applications,
FMCSA exempts, Spencer W.
Alexander, Nelson Alvarez, Cody R.
Anderson, Ronnie L. Barker, Eric D.
Benham, Brian C. Blevins, Charles E.
Bonner, Sr., Michael J. Brieske,
Frederick Brown, William D. Elam, Jr.,
Devin S. Gibson, Lewis M. Hendershott,
Mark E. Henning, Duane C. Jackson,
John J. Long, Jerry A. McMurdy, Steven
L. Miller, Joe E. Montoya, Jonathan A.
Morisoli, Timothy J. Nowak, Lawrence
W. Patterson, Jr., Peter J. Pendola,
Frederick E. Robinson, Larry D.
Schweisberger, Joseph C. Shaw, Michael
Shuler, Kevin C. Simerick, Matthew E.
Sipel, Michael S. Tanko, James P.
Tomasik, Leonard D. Tournear, Booker
T. Ware and Joseph H. Watkins, from
the ITDM standard in 49 CFR
391.41(b)(3), subject to the conditions
listed under ‘‘Conditions and
Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if: (1) The person fails to comply with
the terms and conditions of the
exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained before it was granted; or
(3) continuation of the exemption would
not be consistent with the goals and
VerDate Mar<15>2010
18:27 Jul 01, 2010
Jkt 220001
objectives of 49 U.S.C. 31136(e) and
31315. If the exemption is still effective
at the end of the 2-year period, the
person may apply to FMCSA for a
renewal under procedures in effect at
that time.
Issued on: June 25, 2010.
Larry W. Minor,
Associate Administrator for Policy and
Program Development.
[FR Doc. 2010–16222 Filed 7–1–10; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[FMCSA Docket No. FMCSA–2010–0115]
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
AGENCY: Federal Motor Carrier Safety
Administration (FMCSA), DOT
ACTION: Notice of final disposition.
SUMMARY: FMCSA announces its
decision to exempt thirty-seven
individuals from its rule prohibiting
persons with insulin-treated diabetes
mellitus (ITDM) from operating
commercial motor vehicles (CMVs) in
interstate commerce. The exemptions
will enable these individuals to operate
CMVs in interstate commerce.
DATES: The exemptions are effective July
2, 2010. The exemptions expire on July
2, 2012.
FOR FURTHER INFORMATION CONTACT: Dr.
Mary D. Gunnels, Director, Medical
Programs, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA, Room
W64–224, Department of
Transportation, 1200 New Jersey
Avenue, SE., Washington, DC 20590–
0001. Office hours are from 8:30 a.m. to
5 p.m., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
Friday, except Federal holidays.
Privacy Act: Anyone may search the
electronic form of all comments
received into any of DOT’s dockets by
PO 00000
Frm 00143
Fmt 4703
Sfmt 4703
the name of the individual submitting
the comment (or of the person signing
the comment, if submitted on behalf of
an association, business, labor union, or
other entity). You may review DOT’s
complete Privacy Act Statement in the
Federal Register (65 FR 19477, Apr. 11,
2000). This statement is also available at
https://www.regulations.gov.
Background
On May 21, 2010, FMCSA published
a Notice of receipt of Federal diabetes
exemption applications from thirtyseven individuals and requested
comments from the public (75 FR
28677). The public comment period
closed on June 21, 2010 and one
comment was received.
FMCSA has evaluated the eligibility
of the thirty-seven applicants and
determined that granting the
exemptions to these individuals would
achieve a level of safety equivalent to,
or greater than, the level that would be
achieved by complying with the current
regulation 49 CFR 391.41(b)(3).
Diabetes Mellitus and Driving
Experience of the Applicants
The Agency established the current
standard for diabetes in 1970 because
several risk studies indicated that
drivers with diabetes had a higher rate
of crash involvement than the general
population. The diabetes rule provides
that ‘‘A person is physically qualified to
drive a commercial motor vehicle if that
person has no established medical
history or clinical diagnosis of diabetes
mellitus currently requiring insulin for
control’’ (49 CFR 391.41(b)(3)).
FMCSA established its diabetes
exemption program, based on the
Agency’s July 2000 study entitled ‘‘A
Report to Congress on the Feasibility of
a Program to Qualify Individuals with
Insulin-Treated Diabetes Mellitus to
Operate in Interstate Commerce as
Directed by the Transportation Act for
the 21st Century.’’ The report concluded
that a safe and practicable protocol to
allow some drivers with ITDM to
operate CMVs is feasible. The
September 3, 2003 (68 FR 52441)
Federal Register Notice in conjunction
with the November 8, 2005 (70 FR
67777) Federal Register Notice provides
the current protocol for allowing such
drivers to operate CMVs in interstate
commerce.
These thirty-seven applicants have
had ITDM over a range of 1 to 31 years.
These applicants report no
hypoglycemic reaction that resulted in
loss of consciousness or seizure, that
required the assistance of another
person, or resulted in impaired
cognitive function without warning
E:\FR\FM\02JYN1.SGM
02JYN1
Federal Register / Vol. 75, No. 127 / Friday, July 2, 2010 / Notices
symptoms in the past 5 years (with one
year of stability following any such
episode). In each case, an
endocrinologist verified that the driver
has demonstrated a willingness to
properly monitor and manage his/her
diabetes mellitus, received education
related to diabetes management, and is
on a stable insulin regimen. These
drivers report no other disqualifying
conditions, including diabetes-related
complications. Each meets the vision
standard at 49 CFR 391.41(b)(10).
The qualifications and medical
condition of each applicant were stated
and discussed in detail in the May 21,
2010, Federal Register Notice and they
will not be repeated in this Notice.
emcdonald on DSK2BSOYB1PROD with NOTICES
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315,
FMCSA may grant an exemption from
the diabetes standard in 49 CFR
391.41(b)(3) if the exemption is likely to
achieve an equivalent or greater level of
safety than would be achieved without
the exemption. The exemption allows
the applicants to operate CMVs in
interstate commerce.
To evaluate the effect of these
exemptions on safety, FMCSA
considered medical reports about the
applicants’ ITDM and vision, and
reviewed the treating endocrinologists’
medical opinion related to the ability of
the driver to safely operate a CMV while
using insulin.
Consequently, FMCSA finds that in
each case exempting these applicants
from the diabetes standard in 49 CFR
391.41(b)(3) is likely to achieve a level
of safety equal to that existing without
the exemption.
Conditions and Requirements
The terms and conditions of the
exemption will be provided to the
applicants in the exemption document
and they include the following: (1) That
each individual submit a quarterly
monitoring checklist completed by the
treating endocrinologist as well as an
annual checklist with a comprehensive
medical evaluation; (2) that each
individual reports within 2 business
days of occurrence, all episodes of
severe hypoglycemia, significant
complications, or inability to manage
diabetes; also, any involvement in an
accident or any other adverse event in
a CMV or personal vehicle, whether or
not it is related to an episode of
hypoglycemia; (3) that each individual
provide a copy of the ophthalmologist’s
or optometrist’s report to the medical
examiner at the time of the annual
medical examination; and (4) that each
individual provide a copy of the annual
medical certification to the employer for
VerDate Mar<15>2010
18:27 Jul 01, 2010
Jkt 220001
retention in the driver’s qualification
file, or keep a copy in his/her driver’s
qualification file if he/she is selfemployed. The driver must also have a
copy of the certification when driving,
for presentation to a duly authorized
Federal, State, or local enforcement
official.
Discussion of Comments
FMCSA received one comment in this
proceeding. The comment was
considered and discussed below.
The Pennsylvania Department of
Transportation stated that it had
reviewed the driving record for Scott A.
Yon and was in favor of granting a
Federal diabetes exemption to this
individual.
Conclusion
Based upon its evaluation of the
thirty-seven exemption applications,
FMCSA exempts, Billy Banks, Joseph P.
Beagan, John M. Charlton, Stuart A.
Dietz, Marie C. Eddy, Michael G.
Eikenberry, Francisco K. Gallardo, John
P. Gould, David B. Graef, Jason C.
Green, Kimmy D. Hall, Bruce G.
Hammill, Jr., Edward G. Harbin,
Timothy R. Hefling, Christopher M.
Hultman, Michael R. Jackson, Gerald A.
Johnson, Jay T. Kirschmann, Duane K.
Kohls, John F. Lohmuller, Rodney A.
Markham, Christopher P. Martin, H.
Alan Miller, Andrew D. Monson, Cheryl
T. Murphy, Kurt D. Oertelt, Joseph M.
Pirrello, Audrey R. Roddy, Theodore J.
Rolfe, Ross R. Romano, Max S. Sklarski,
Gerald J. Solwey, Darren G. Steil, Jason
D. Sweet, Robert M. Thomson, Kevin R.
Welch and Scott A. Yon, from the ITDM
standard in 49 CFR 391.41(b)(3), subject
to the conditions listed under
‘‘Conditions and Requirements’’ above.
In accordance with 49 U.S.C. 31136(e)
and 31315 each exemption will be valid
for two years unless revoked earlier by
FMCSA. The exemption will be revoked
if: (1) The person fails to comply with
the terms and conditions of the
exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained before it was granted; or
(3) continuation of the exemption would
not be consistent with the goals and
objectives of 49 U.S.C. 31136(e) and
31315. If the exemption is still effective
at the end of the 2-year period, the
person may apply to FMCSA for a
renewal under procedures in effect at
that time.
Issued on: June 28, 2010.
Larry W. Minor,
Associate Administration for Policy and
Program Development.
[FR Doc. 2010–16225 Filed 7–1–10; 8:45 am]
BILLING CODE 4910–EX–P
PO 00000
Frm 00144
Fmt 4703
Sfmt 4703
38599
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2010–0203]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
AGENCY: Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of applications for
exemption, request for comments.
SUMMARY: FMCSA announces receipt of
applications from seventeen individuals
for an exemption from the prohibition
against persons with a clinical diagnosis
of epilepsy (or any other condition
which is likely to cause a loss of
consciousness or any loss of ability to
operate a commercial motor vehicle
(CMV)) from operating CMVs in
interstate commerce. If granted, the
exemptions would enable these
individuals with seizure disorders to
operate CMVs in interstate commerce.
DATES: Comments must be received on
or before August 2, 2010.
ADDRESSES: You may submit comments
bearing the Federal Docket Management
System (FDMS) Docket No. FMCSA–
2010–0203 using any of the following
methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov. Follow the
on-line instructions for submitting
comments.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue, SE., West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery: West Building
Ground Floor, Room W12–140, 1200
New Jersey Avenue, SE., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal
Holidays.
• Fax: 1–202–493–2251.
Instructions: Each submission must
include the Agency name and the
docket No. for this Notice. Note that
DOT posts all comments received
without change to https://
www.regulations.gov, including any
personal information included in a
comment. Please see the Privacy Act
heading below.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov at any time or
Room W12–140 on the ground level of
the West Building, 1200 New Jersey
Avenue, SE., Washington, DC, between
9 a.m. and 5 p.m., Monday through
E:\FR\FM\02JYN1.SGM
02JYN1
Agencies
[Federal Register Volume 75, Number 127 (Friday, July 2, 2010)]
[Notices]
[Pages 38598-38599]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-16225]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[FMCSA Docket No. FMCSA-2010-0115]
Qualification of Drivers; Exemption Applications; Diabetes
Mellitus
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT
ACTION: Notice of final disposition.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces its decision to exempt thirty-seven
individuals from its rule prohibiting persons with insulin-treated
diabetes mellitus (ITDM) from operating commercial motor vehicles
(CMVs) in interstate commerce. The exemptions will enable these
individuals to operate CMVs in interstate commerce.
DATES: The exemptions are effective July 2, 2010. The exemptions expire
on July 2, 2012.
FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Director, Medical
Programs, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room W64-224,
Department of Transportation, 1200 New Jersey Avenue, SE., Washington,
DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday
through Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
Electronic Access
You may see all the comments online through the Federal Document
Management System (FDMS) at: https://www.regulations.gov.
Docket: For access to the docket to read background documents or
comments, go to https://www.regulations.gov and/or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue, SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: Anyone may search the electronic form of all comments
received into any of DOT's dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, or other
entity). You may review DOT's complete Privacy Act Statement in the
Federal Register (65 FR 19477, Apr. 11, 2000). This statement is also
available at https://www.regulations.gov.
Background
On May 21, 2010, FMCSA published a Notice of receipt of Federal
diabetes exemption applications from thirty-seven individuals and
requested comments from the public (75 FR 28677). The public comment
period closed on June 21, 2010 and one comment was received.
FMCSA has evaluated the eligibility of the thirty-seven applicants
and determined that granting the exemptions to these individuals would
achieve a level of safety equivalent to, or greater than, the level
that would be achieved by complying with the current regulation 49 CFR
391.41(b)(3).
Diabetes Mellitus and Driving Experience of the Applicants
The Agency established the current standard for diabetes in 1970
because several risk studies indicated that drivers with diabetes had a
higher rate of crash involvement than the general population. The
diabetes rule provides that ``A person is physically qualified to drive
a commercial motor vehicle if that person has no established medical
history or clinical diagnosis of diabetes mellitus currently requiring
insulin for control'' (49 CFR 391.41(b)(3)).
FMCSA established its diabetes exemption program, based on the
Agency's July 2000 study entitled ``A Report to Congress on the
Feasibility of a Program to Qualify Individuals with Insulin-Treated
Diabetes Mellitus to Operate in Interstate Commerce as Directed by the
Transportation Act for the 21st Century.'' The report concluded that a
safe and practicable protocol to allow some drivers with ITDM to
operate CMVs is feasible. The September 3, 2003 (68 FR 52441) Federal
Register Notice in conjunction with the November 8, 2005 (70 FR 67777)
Federal Register Notice provides the current protocol for allowing such
drivers to operate CMVs in interstate commerce.
These thirty-seven applicants have had ITDM over a range of 1 to 31
years. These applicants report no hypoglycemic reaction that resulted
in loss of consciousness or seizure, that required the assistance of
another person, or resulted in impaired cognitive function without
warning
[[Page 38599]]
symptoms in the past 5 years (with one year of stability following any
such episode). In each case, an endocrinologist verified that the
driver has demonstrated a willingness to properly monitor and manage
his/her diabetes mellitus, received education related to diabetes
management, and is on a stable insulin regimen. These drivers report no
other disqualifying conditions, including diabetes-related
complications. Each meets the vision standard at 49 CFR 391.41(b)(10).
The qualifications and medical condition of each applicant were
stated and discussed in detail in the May 21, 2010, Federal Register
Notice and they will not be repeated in this Notice.
Basis for Exemption Determination
Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
from the diabetes standard in 49 CFR 391.41(b)(3) if the exemption is
likely to achieve an equivalent or greater level of safety than would
be achieved without the exemption. The exemption allows the applicants
to operate CMVs in interstate commerce.
To evaluate the effect of these exemptions on safety, FMCSA
considered medical reports about the applicants' ITDM and vision, and
reviewed the treating endocrinologists' medical opinion related to the
ability of the driver to safely operate a CMV while using insulin.
Consequently, FMCSA finds that in each case exempting these
applicants from the diabetes standard in 49 CFR 391.41(b)(3) is likely
to achieve a level of safety equal to that existing without the
exemption.
Conditions and Requirements
The terms and conditions of the exemption will be provided to the
applicants in the exemption document and they include the following:
(1) That each individual submit a quarterly monitoring checklist
completed by the treating endocrinologist as well as an annual
checklist with a comprehensive medical evaluation; (2) that each
individual reports within 2 business days of occurrence, all episodes
of severe hypoglycemia, significant complications, or inability to
manage diabetes; also, any involvement in an accident or any other
adverse event in a CMV or personal vehicle, whether or not it is
related to an episode of hypoglycemia; (3) that each individual provide
a copy of the ophthalmologist's or optometrist's report to the medical
examiner at the time of the annual medical examination; and (4) that
each individual provide a copy of the annual medical certification to
the employer for retention in the driver's qualification file, or keep
a copy in his/her driver's qualification file if he/she is self-
employed. The driver must also have a copy of the certification when
driving, for presentation to a duly authorized Federal, State, or local
enforcement official.
Discussion of Comments
FMCSA received one comment in this proceeding. The comment was
considered and discussed below.
The Pennsylvania Department of Transportation stated that it had
reviewed the driving record for Scott A. Yon and was in favor of
granting a Federal diabetes exemption to this individual.
Conclusion
Based upon its evaluation of the thirty-seven exemption
applications, FMCSA exempts, Billy Banks, Joseph P. Beagan, John M.
Charlton, Stuart A. Dietz, Marie C. Eddy, Michael G. Eikenberry,
Francisco K. Gallardo, John P. Gould, David B. Graef, Jason C. Green,
Kimmy D. Hall, Bruce G. Hammill, Jr., Edward G. Harbin, Timothy R.
Hefling, Christopher M. Hultman, Michael R. Jackson, Gerald A. Johnson,
Jay T. Kirschmann, Duane K. Kohls, John F. Lohmuller, Rodney A.
Markham, Christopher P. Martin, H. Alan Miller, Andrew D. Monson,
Cheryl T. Murphy, Kurt D. Oertelt, Joseph M. Pirrello, Audrey R. Roddy,
Theodore J. Rolfe, Ross R. Romano, Max S. Sklarski, Gerald J. Solwey,
Darren G. Steil, Jason D. Sweet, Robert M. Thomson, Kevin R. Welch and
Scott A. Yon, from the ITDM standard in 49 CFR 391.41(b)(3), subject to
the conditions listed under ``Conditions and Requirements'' above.
In accordance with 49 U.S.C. 31136(e) and 31315 each exemption will
be valid for two years unless revoked earlier by FMCSA. The exemption
will be revoked if: (1) The person fails to comply with the terms and
conditions of the exemption; (2) the exemption has resulted in a lower
level of safety than was maintained before it was granted; or (3)
continuation of the exemption would not be consistent with the goals
and objectives of 49 U.S.C. 31136(e) and 31315. If the exemption is
still effective at the end of the 2-year period, the person may apply
to FMCSA for a renewal under procedures in effect at that time.
Issued on: June 28, 2010.
Larry W. Minor,
Associate Administration for Policy and Program Development.
[FR Doc. 2010-16225 Filed 7-1-10; 8:45 am]
BILLING CODE 4910-EX-P